BioDtech

About:

BioDtech develops and commercializes reagents and systems for the detection, neutralization, and removal of endotoxin for researchers.

Website: http://www.biodtechinc.com

Description:

Biodtech, Inc. develops and markets a line of reagents and systems for the detection, neutralization, and removal of endotoxin to researchers in bioresearch and bioprocess markets. It offers various detection solutions, including EndoDtec-F, a reagent that is used to uncover bacteria in environmental samples, injectable drugs, and medical devices, as well as on surfaces; sushi Δ3 anti-sera that allows investigators to perform independent ELISA and western blot studies; and EndoPrep, a sample treatment system to remove the inhibitory or enhancing effects of proteins, peptides, and antibodies in endotoxin assays. The company also provides EndoBind-R, a removal reagent that removes endotoxins from aqueous samples; EndoZap-R, an endotoxin neutralization peptide that is used as an anti-microbial; endotoxin-free water; and endotoxin detection and removal services. Biodtech, Inc. was founded in 2003 and is based in Birmingham, Alabama.

Total Funding Amount:

$575000

Headquarters Location:

Birmingham, Alabama, United States

Founded Date:

2003-01-01

Contact Email:

info(AT)biodtechinc.com

Founders:

Ira Weiss

Number of Employees:

1-10

Last Funding Date:

2010-08-25

IPO Status:

Private

Industries:

© 2025 bioDAO.ai